Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonvariceal upper gastrointestinal bleeding.

C Rollhauser1, D E Fleischer

  • 1Gastroenterology Division, University of Tennessee Medical Center, Knoxville, Tennessee 37920, USA. crollhau@mc.utcmk.edu

Endoscopy
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter study on the diagnostic performance of multiframe volumetric laser endomicroscopy targets for Barrett's esophagus neoplasia with histopathology correlation.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2020
Same author

International cancer seminars: a focus on esophageal squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

The clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with Jackhammer esophagus versus Nutcracker esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Incidence of brain metastasis from esophageal cancer.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Esophageal leukoplakia: a rare cause of white patches in esophagus with malignant potential.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2014
Same author

Prospective feasibility study on the use of multiband mucosectomy for endoscopic resection of early squamous neoplasia in the esophagus.

Endoscopy·2012

Recent studies show proton-pump inhibitors improve outcomes for nonvariceal upper gastrointestinal bleeding (NVUGIB) when used with endoscopic therapy. Further research is needed to define erythromycin's role and optimize PPI treatment for NVUGIB.

Area of Science:

  • Gastroenterology
  • Endoscopy
  • Internal Medicine

Background:

  • Nonvariceal upper gastrointestinal bleeding (NVUGIB) presents persistent challenges with unchanged case fatality rates despite potential incidence decline.
  • Current management strategies for NVUGIB require ongoing evaluation to improve patient outcomes.

Purpose of the Study:

  • To review and synthesize recent findings on medical and endoscopic therapies for nonvariceal upper gastrointestinal bleeding.
  • To assess the efficacy and optimal use of emerging and established treatments for NVUGIB.

Main Methods:

  • Systematic review of recent clinical studies and trials concerning NVUGIB management.
  • Analysis of data on the effectiveness of proton-pump inhibitors, erythromycin, endoscopic techniques, and novel therapies.

Related Experiment Videos

Main Results:

  • Proton-pump inhibitors (PPIs) combined with endoscopic therapy consistently reduce rebleeding rates in NVUGIB, though optimal administration protocols need further definition.
  • Erythromycin shows potential as an adjunctive therapy, warranting further investigation.
  • Established endoscopic methods like injection and thermocoagulation, especially in combination, remain preferable to hemoclips; newer techniques like cryotherapy lack widespread application.

Conclusions:

  • Combination endoscopic therapy with PPIs is a cornerstone in managing NVUGIB, reducing rebleeding.
  • While promising, the roles of erythromycin and newer endoscopic modalities require further clinical validation.
  • Optimizing current therapeutic regimens and exploring novel endoscopic approaches are crucial for improving NVUGIB outcomes.